Company Performance Metrics
Robert Dunne: Chief Executive Officer
Roisin Thompson: Chief Technical Officer
GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), enhanced tools for the analysis and selective purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in:
- Basic R&D – Glycobiology & Glycoproteomics.
- Biomarker Discover &
Biomedical Diagnostics.
- The Biopharmaceutical Industry.
- Vaccines
- Cosmetics
GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant advantages over existing commercially available lectins products including:
- Simplified, rapid & cost effective production through recombinant expression in Escherichia coli.
- High purity & consistent performance.
- Genetically enhanced glycan binding properties (specificity & affinity).
- Scalable production facilitating utilization for large scale applications.
